This arthritis drug cost $198 in 2008. Now it`s more than $10,000
19 Oct 2021 //
AXIOS
Medivir taps ex-Acadia chief Uli Hacksell as interim CEO; Merck onboards CDO
19 Oct 2018 //
ENDPTS
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
23 Aug 2017 //
PMLIVE
Senate probe keeps heat on J&J, Mylan, Depomed,others for their opioid marketing
30 Mar 2017 //
FIERCE PHARMA
Another exec departs troubled Endo--and this time, it`s for another drugmaker
21 Oct 2016 //
FIERCE PHARMA
Card-carrying pharma reps? Chicago eyes licensing for painkiller promoters
19 Oct 2016 //
FIERCE PHARMA
Depomed strikes unexpected deal with activist Starboard, adding J&J, Abbott
19 Oct 2016 //
FIERCE PHARMA
Depomed wins Nucynta patent fight, but does that harm or help in proxy battle?
03 Sep 2016 //
FIERCE PHARMA
Depomed Announces Patent Trial and Appeal Board Denial of Inter Partes Review
18 Jul 2016 //
PR NEWSWIRE
Depomed proposes 4-month wait for vote on board overhaul
24 Jun 2016 //
FIERCE PHARMA
Simmering Power Struggle Between Depomed and Hedge Fund Starboard Comes to Boil
15 Apr 2016 //
BIOSPACE
Depomed Rises After Starboard Value Seeks Control of Board
10 Apr 2016 //
BLOOMBERG
UPDATED: Hedge fund aims to oust Depomed board for `troubling record`
10 Apr 2016 //
FIERCE PHARMA
Three Underperforming Biopharma Companies Worth Looking At
15 Feb 2016 //
BIOSPACE
Depomed gets favorable US court ruling in Nucynta & Nucynta ER patent litigation
09 Feb 2016 //
PHARMABIZ
Grunenthal Denied Indian Patent Use of Tapentadol to Treat Osteoarthritis Pain
27 Jan 2016 //
TWOFOUR INSIGHT
Depomed isn`t anti-takeover, CEO says. It was just anti-Horizon
13 Jan 2016 //
FIERCE PHARMA
After Dropping Depomed,Horizon Forks Over $510Mn Cash for Crealta Holdings
11 Dec 2015 //
BIOSPACE
Horizon drops hostile takeover attack on Depomed after legal ruling
20 Nov 2015 //
FIERCE PHARMA
Depomed buys a late-stage pain drug and settles its Endo suit in one swipe
18 Nov 2015 //
FIERCE BIOTECH
Depomed Acquires U.S. Rights, First-in-Class Pain Product from Grunenthal
17 Nov 2015 //
PR NEWSWIRE
Depomed`s staffed-up Nucynta salesforce starts bringing home the bacon
16 Nov 2015 //
FIERCE PHARMA MARKETING
Chicago make second run at Allergan,J&J,Purdue & others with painkiller lawsuit
09 Nov 2015 //
FIERCE PHARMA
Hostile Takeover Attempt of Depomed,Triple Size of US Headquarter
05 Oct 2015 //
BIOSPACE
Note to Depomed shareholders: Let Horizon call its meetings, ISS advises
28 Sep 2015 //
FIERCE PHARMA
Horizon Pharma plc Has Commenced Solicitation of Depomed, Inc. Shareholders for Calling of Special Meetings
10 Sep 2015 //
FIERCE PHARMA
Depomed Issues Statement on Horizon Pharma plc`s Unsolicited Exchange Offer
08 Sep 2015 //
PR NEWS WIRE
Impatient Horizon accuses Depomed of stalling its shareholder meeting plans
27 Aug 2015 //
FIERCE PHARMA
Horizon puts forth its slate of new Depomed directors
19 Aug 2015 //
FIERCE PHARMA
Horizon bows to Depomed`s demands with new bid--but adds demands of its own
13 Aug 2015 //
FIERCE PHARMA
Horizon has said it`s ready to up its bid, Depomed CEO says. So where`s the new offer?
08 Aug 2015 //
FIERCE PHARMA
Depomed Sends Letter to Horizon Pharma
07 Aug 2015 //
PR NEWS WIRE
We warned you, Depomed: Horizon pushes down hostile path
03 Aug 2015 //
FIERCE PHARMA
Depomed pooh-poohs Horizon`s new bid in latest rejection
30 Jul 2015 //
FIERCE PHARMA
Horizon hikes Depomed offer to $2B in bid for `friendly` deal talks
21 Jul 2015 //
FIERCE PHARMA
Horizon Pharma goes hostile with $3 billion offer for Depomed
08 Jul 2015 //
REUTERS